![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Transgene Sa | LSE:0OCQ | London | Ordinary Share | FR0005175080 | TRANSGENE ORD SHS |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 3.04 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 7.9M | -22.33M | -0.2214 | -5.06 | 306.59M |
Au titre du contrat de liquidité confié par Transgene à Natixis Oddo BHF SCA, à la date du 30 juin 2024, les moyens suivants figuraient au compte de liquidité :
Au cours du premier semestre 2024, il a été négocié un total de :
Achat | 204 900 titres | 248 651 € | 894 transactions |
Vente | 169 972 titres | 217 858 € | 769 transactions |
Il est rappelé :
Contacts
Transgene Lucie Larguier Directrice Financière +33 (0)3 88 27 91 00 investorrelations@transgene.fr |
Pièce jointe
1 Year Transgene Chart |
1 Month Transgene Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions